Interventions to reduce HIV transmission related to injecting drug use in prison
- PMID: 19095196
- DOI: 10.1016/S1473-3099(08)70305-0
Interventions to reduce HIV transmission related to injecting drug use in prison
Abstract
The high prevalence of HIV infection and drug dependence among prisoners, combined with the sharing of injecting drug equipment, make prisons a high-risk environment for the transmission of HIV. Ultimately, this contributes to HIV epidemics in the communities to which prisoners return on their release. We reviewed the effectiveness of interventions to reduce injecting drug use risk behaviours and, consequently, HIV transmission in prisons. Many studies reported high levels of injecting drug use in prisons, and HIV transmission has been documented. There is increasing evidence of what prison systems can do to prevent HIV transmission related to injecting drug use. In particular, needle and syringe programmes and opioid substitution therapies have proven effective at reducing HIV risk behaviours in a wide range of prison environments, without resulting in negative consequences for the health of prison staff or prisoners. The introduction of these programmes in countries with an existing or emergent epidemic of HIV infection among injecting drug users is therefore warranted, as part of comprehensive programmes to address HIV in prisons.
Similar articles
-
HIV and incarceration: prisons and detention.J Int AIDS Soc. 2011 May 19;14:26. doi: 10.1186/1758-2652-14-26. J Int AIDS Soc. 2011. PMID: 21595957 Free PMC article. Review.
-
Access to harm reduction and HIV-related treatment services inside Indian prisons: experiences of formerly incarcerated injecting drug users.Int J Prison Health. 2013;9(2):82-91. doi: 10.1108/17449201311326952. Int J Prison Health. 2013. PMID: 25758440
-
Indonesian prisons and HIV: part of the problem, part of the solution?Acta Med Indones. 2009 Jul;41 Suppl 1:52-6. Acta Med Indones. 2009. PMID: 19920299
-
People who inject drugs in prison: HIV prevalence, transmission and prevention.Int J Drug Policy. 2015 Feb;26 Suppl 1:S12-5. doi: 10.1016/j.drugpo.2014.10.012. Epub 2014 Dec 1. Int J Drug Policy. 2015. PMID: 25727258
-
HIV in prison in low-income and middle-income countries.Lancet Infect Dis. 2007 Jan;7(1):32-41. doi: 10.1016/S1473-3099(06)70685-5. Lancet Infect Dis. 2007. PMID: 17182342 Review.
Cited by
-
Coexisting social conditions and health problems among clients seeking treatment for illicit drug use in Finland: the HUUTI study.BMC Public Health. 2013 Apr 23;13:380. doi: 10.1186/1471-2458-13-380. BMC Public Health. 2013. PMID: 23617549 Free PMC article.
-
Drug use and opioid substitution treatment for prisoners.Harm Reduct J. 2010 Jul 19;7:17. doi: 10.1186/1477-7517-7-17. Harm Reduct J. 2010. PMID: 20642849 Free PMC article.
-
HIV and incarceration: prisons and detention.J Int AIDS Soc. 2011 May 19;14:26. doi: 10.1186/1758-2652-14-26. J Int AIDS Soc. 2011. PMID: 21595957 Free PMC article. Review.
-
HIV among people who use drugs: a global perspective of populations at risk.J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 1(Suppl 1):S17-22. doi: 10.1097/QAI.0b013e3181f9c04c. J Acquir Immune Defic Syndr. 2010. PMID: 21045594 Free PMC article.
-
Age-Specific Global Prevalence of Hepatitis B, Hepatitis C, HIV, and Tuberculosis Among Incarcerated People: A Systematic Review.J Adolesc Health. 2018 Mar;62(3S):S18-S26. doi: 10.1016/j.jadohealth.2017.09.030. J Adolesc Health. 2018. PMID: 29455713 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical